STOCK TITAN

Innoviva (NASDAQ: INVA) holders approve board, pay and 2026 equity plan

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Innoviva, Inc. reported results from its Annual Meeting of Stockholders held on May 4, 2026. Stockholders elected five directors for one-year terms ending at the 2027 annual meeting, including Chief Executive Officer Pavel Raifeld, with each nominee receiving a strong majority of votes cast.

Stockholders approved, on a non-binding advisory basis, Innoviva’s executive compensation and ratified the Audit Committee’s selection of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. They also approved Innoviva’s 2026 Equity Incentive Plan, supporting the company’s ongoing compensation and governance framework.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Say-on-pay support 56,243,880 shares for Non-binding advisory vote on executive compensation
Say-on-pay opposition 2,836,001 shares against Non-binding advisory vote on executive compensation
Auditor ratification votes for 66,008,453 shares for Ratification of Deloitte & Touche LLP for fiscal year ending December 31, 2026
2026 Equity Plan approval 55,435,111 shares for Approval of Innoviva’s 2026 Equity Incentive Plan
Votes for Pavel Raifeld 58,880,013 shares for Election to board of directors for term expiring at 2027 annual meeting
Broker non-votes 6,809,010 shares Reported on multiple voting items at the annual meeting
non-binding advisory basis regulatory
"our stockholders next approved on a non-binding advisory basis, Innoviva’s executive compensation"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
broker non-votes financial
"and 6,809,010 shares of broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm regulatory
"as our independent registered public accounting firm for the fiscal year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
2026 Equity Incentive Plan financial
"our stockholders also approved Innoviva’s 2026 Equity Incentive Plan"
Annual Meeting of Stockholders regulatory
"At the Annual Meeting of Stockholders held on May 4, 2026"
false 0001080014 0001080014 2026-05-04 2026-05-04
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 4, 2026

 

 

INNOVIVA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   000-30319   94-3265960

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

1350 Old Bayshore Highway,

Suite 400

Burlingame, California

94010

(650) 238-9600

(Addresses, including zip code, and telephone numbers, including area code, of principal executive offices)

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   INVA   The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.07.

Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders held on May 4, 2026 (the “Meeting”), the stockholders of Innoviva, Inc. (“Innoviva”) elected five members to our board of directors, each for a one-year term expiring at the annual meeting of stockholders in 2027, as follows:

 

Members

   Number of
Shares Voted
For
     Number of
Shares Voted
Against or
Abstained
     Broker
Non-Votes
 

Derek Small

     56,752,327        2,485,600        6,809,010  

Mark A. DiPaolo, Esq.

     50,072,119        9,165,808        6,809,010  

Jules Haimovitz

     56,834,625        2,403,302        6,809,010  

Sarah J. Schlesinger, M.D.

     53,509,479        5,728,448        6,809,010  

Pavel Raifeld

     58,880,013        357,914        6,809,010  

At the Meeting, our stockholders next approved on a non-binding advisory basis, Innoviva’s executive compensation. The vote for such approval was 56,243,880 shares for, 2,836,001 shares against, 158,046 shares abstaining, and 6,809,010 shares of broker non-votes.

Also at the Meeting, our stockholders next ratified the selection by the Audit Committee of the Board of Directors of Innoviva of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote for such ratification was 66,008,453 shares for, 16,574 shares against, 21,910 shares abstaining and 0 broker non-votes.

At the Meeting, our stockholders also approved Innoviva’s 2026 Equity Incentive Plan. The vote for such approval was 55,435,111 shares for, 3,766,788 shares against, 36,028 shares abstaining, and 6,809,010 shares of broker non-votes.


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    INNOVIVA, INC.
Date: May 4, 2026     By:  

/s/ Pavel Raifeld

      Pavel Raifeld
      Chief Executive Officer

FAQ

What did Innoviva (INVA) shareholders approve at the May 4, 2026 annual meeting?

Innoviva shareholders approved all key proposals at the May 4, 2026 meeting. They elected five directors for one-year terms, endorsed executive compensation on an advisory basis, ratified Deloitte & Touche LLP as auditor for 2026, and approved the company’s 2026 Equity Incentive Plan.

How did Innoviva (INVA) shareholders vote on executive compensation in 2026?

Innoviva shareholders approved executive compensation on a non-binding advisory basis. The vote totaled 56,243,880 shares for, 2,836,001 shares against and 158,046 abstentions, with 6,809,010 broker non-votes, indicating broad, though not unanimous, support for the company’s pay practices in 2026.

Which auditor did Innoviva (INVA) shareholders ratify for the 2026 fiscal year?

Shareholders ratified Deloitte & Touche LLP as Innoviva’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification vote was 66,008,453 shares for, 16,574 shares against and 21,910 abstentions, with no broker non-votes reported.

What is Innoviva’s 2026 Equity Incentive Plan and how was it approved?

Innoviva’s 2026 Equity Incentive Plan is a stock-based compensation program approved by shareholders at the annual meeting. The proposal received 55,435,111 shares for, 3,766,788 shares against and 36,028 abstentions, plus 6,809,010 broker non-votes, supporting continued equity-based incentives for eligible participants.

Who was elected to Innoviva’s board of directors at the 2026 annual meeting?

Five directors were elected for one-year terms expiring at the 2027 annual meeting: Derek Small, Mark A. DiPaolo, Esq., Jules Haimovitz, Sarah J. Schlesinger, M.D., and Chief Executive Officer Pavel Raifeld. Each director received a majority of votes cast, with additional broker non-votes recorded.

How strong was support for Innoviva CEO Pavel Raifeld’s board election in 2026?

Support for CEO Pavel Raifeld’s election as director was high. He received 58,880,013 shares voted for and 357,914 shares voted against or abstaining, along with 6,809,010 broker non-votes, indicating clear backing from voting shareholders at the 2026 annual meeting.

Filing Exhibits & Attachments

3 documents